Subscribe

login / sign up

close and back to page

Bayer Announces WHO Pre-Qualification for Fludora Fusion to Combat Malaria

Addresses the threat of insecticide resistant mosquitoes.

BAYER

The recent WHO Malaria Report 2018 flagged another stalling in the progress towards elimination of the disease, in part due to development of insecticide resistance in vector mosquitoes to current preventative solutions. There is therefore an urgent need to maintain investment into innovation for malaria vector control; to develop new modes of action but also to implement strategies which ensure their sustainability. Fludora™ Fusion, the first product of its kind to combine different modes of action, is a prime example of one such strategy.

Read More Show Less

Bayer's Damion Jones Addresses Intersectionality and How to Find Common Ground with Peers

"If we can connect well, we can collaborate well, and if we can collaborate well we can innovate well as an organization," says Jones, Global Director of Inclusion and Diversity for Bayer U.S.

Bayer: Vote for Your Favorite Social Impact Pioneers

The international awards from the Bayer Foundations honor groundbreaking solutions to humanity's biggest challenges in health and nutrition to the benefit of the rising billions in need. Public voting winner will be announced on October 25, 2018.

Originally Published by Bayer.

It's your turn to choose! The Aspirin Social Innovation Award 2018 is underway and interested parties have until October 25, 2018 to vote for their favorite social impact pioneers. This year, 28 projects from 16 countries have been nominated for the award endowed with EUR 100,000. Five winners will each be awarded EUR 20,000 for their groundbreaking approaches to humanity's biggest challenges in health and nutrition. Four of these winners will be chosen by an expert jury on November 12 in Berlin, and one will be selected by the public through an online vote. For the second time in the award's history, the foundation will additionally select a "Special China Award" winner to increase awareness of social innovations in China.

Everyone has until October 25, 2018 to vote for their favorite project at https://aspirin-social-awards.org/public-voting.

The Aspirin Social Innovation Award honors groundbreaking social impact innovations in health and nutrition from around the world that have the potential to bring about systematic change for the rising billions in need. Award-winners are social impact pioneers whose innovations offer new solutions to improve health care or to end global hunger. The collective power of the 2017 winners has the potential to solve challenges that over 2 billion people on the planet are facing. Their innovations showcase how entrepreneurial spirit can change the lives of the rising billions in need.

Bayer Collaborates with One Acre Fund to Support Smallholders in Africa with a Donation of EUR 700,000

Project aims to improve African smallholder farmers' incomes and enable better nutrition for their families.

Originally Published by Bayer.

As part of Bayer's long-term goal to improve the lives of smallholder farmers and their families, the company donated EUR 700,000 to One Acre Fund, a non-profit social enterprise supplying smallholder farmers with the financing, tools and training they need to succeed. The donation will allow One Acre Fund to pursue two innovative services for farmers in Kenya and Rwanda: improved poultry products and digital technologies. At scale, these innovations could reach nearly 600,000 smallholder farmers in Kenya and Rwanda.

Read More Show Less

Stefan Oelrich to Join Bayer Board of Management and Head Pharmaceuticals Division

Oelrich will succeed Dieter Weinand, who is leaving the company as of November 1, 2018 and joining the Executive Committee of Sanofi and will be based in the United States.

Originally Published by Bayer.

The Supervisory Board of Bayer AG has appointed Stefan Oelrich (50) to the company's Board of Management. He will succeed Dieter Weinand as head of the Pharmaceuticals Division as of November 1, 2018. Weinand is leaving the company for family reasons. He will be joining the Executive Committee of Sanofi and will be based in the United States. Oelrich is currently a member of the Executive Committee of Sanofi with responsibility for the global diabetes and cardiovascular business. He previously had a long career in Bayer's Pharmaceuticals business.

Read More Show Less

Bayer Completes Biggest Acquisition in its History

"We are now a leader in the agricultural industry with a clear commitment to innovation and sustainability – for the benefit of our customers and society."

Originally Published by Bayer.

Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjusted basis (Fx & portfolio adj.). "We are on track to achieve our annual targets," said Werner Baumann, Chairman of the Board of Management, when he presented the interim report on Wednesday. EBITDA before special items increased thanks to growth at Crop Science and Animal Health. Bayer has adjusted its Group outlook to account for the sales and earnings contributions from Monsanto from the date of the acquisition. The company aims to pay out a dividend per share for 2018 that is at least at the same level as in the prior year.

Read More Show Less

Bayer: Conditions for Beginning Monsanto Integration Fulfilled

The acquisition of Monsanto gives rise to a leading agriculture company with a high level of innovative strength, a strong product portfolio and the highest ethical standards.

REUTERS

Originally Published by Monsanto.

The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros. Bayer already became the sole owner of Monsanto Company on June 7, 2018.

Read More Show Less

LEO Pharma to Expand its Lead in Medical Dermatology with Acquisition of Bayer's Prescription Dermatology Unit

Significant step to bolster LEO Pharma's role as a leading global dermatology company with its goal of helping 125 million patients by 2025.

Originally Published by Bayer.

LEO Pharma and Bayer announced, that LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription treatments for acne, fungal skin infections and rosacea, and a range of topical steroids with an annual turnover in 2017 of more than 280 million euros. It will enable LEO Pharma to expand significantly in key markets worldwide and broaden its therapeutic areas.

Read More Show Less

Bayer Foundation Awards 26 Scholarships for Science Camp During Summer Vacation: Young Scientists Experimenting on Health and Food science topics at Bayer Science Teens Camp in the U.S.

International exchange: Pupils from Germany, India, Africa and the U.S. taking part in two-week, hands-on seminar focusing on life science, medical health and food science topics ; Bayer partnering with renowned Center for STEM Learning at University of Colorado in Boulder

Originally Published by Bayer.

One of the year's sporting highlights, the final of this year's Soccer World Cup, is only just over. The highlight of the summer for 26 teenagers from four continents is the Bayer Science Teens Camp in the U.S. Thanks to scholarships awarded by the Bayer Science & Education Foundation these 26 Bayer Science Teens are going to be researching into a wide variety of life science, medical health and food science topics in Colorado from 23 July to 4 August. The multinational make-up of the Bayer Science Teens Camp, with youngsters participating from Germany, several African countries, India and the U.S., opens up plenty of valuable opportunities to get to know teenagers from very different cultural backgrounds.

Read More Show Less

Bayer Animal Health and Mitsui Chemicals Agro Sign Global License Agreement

Bayer to expand its strong parasiticide portfolio for companion animals with new compounds derived from MCAG's chemical library; license agreement is the result of the long-term collaboration between Bayer and MCAG.

Originally Published by Bayer.

Bayer Animal Health GmbH and Mitsui Chemicals Agro, Inc. (MCAG) have signed a global license agreement to advance innovative parasiticides for companion animals based on MCAG's innovation and technology. As part of the license agreement, Bayer will develop and commercialize novel compounds based on intellectual property from MCAG. Further terms of the agreement were not disclosed.

Read More Show Less

Originally Published by Bayer.

The Bayer Group is reinforcing its commitment to the rights of lesbian, gay, bisexual, transgender and intersex (LGBTI) people through the Group's support of the new United Nations anti-discrimination standards. "For many years now, Bayer has taken a diverse approach to demonstrating its commitment to the rights of LGBTI people within our organization and our area of influence," wrote Werner Baumann, CEO of Bayer AG, in a letter to Fabrice Houdart, an officer at the UN High Commissioner for Human Rights in New York.

Read More Show Less

Bayer Issues New Bonds With a  Volume of 15 billion U.S. Dollars

Successful international placement secures long-term financing of the Monsanto acquisition / Issue of eight tranches with maturities of three to 30 years was approximately three times oversubscribed

Originally Published by Bayer.

Via its subsidiary, Bayer U.S. Finance II LLC, Pittsburgh, United States, the Bayer Group is issuing bonds with a volume of 15 billion U.S. dollars guaranteed by Bayer AG. The placement comprises eight tranches with differing maturities and exclusively targets international institutional investors. It was approximately three times oversubscribed and will secure the long-term financing of the Monsanto acquisition.

Read More Show Less
© Copyright 2018 — DiversityInc All Rights Reserved.